Safety and efficacy of an extravascular, water-soluble sealant for vascular closure: Initial clinical results for Mynx™ (Catheterization and Cardiovascular Intervention (2007) 70, 627-633 DOI: 10.1002/ccd.21353);The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: Initial clinical results for Mynx™

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 5, 2007, Pages 627-633

  Scheinert, D ^a   Sievert, H ^b   Turco, M A ^c   Schmidt, A ^a   Hauptmann, K E ^d   Mueller, R ^e   Dadourian, D ^f   Krankenberg, H ^g   Grube, E ^e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c WASHINGTON ADVENTIST HOSPITAL   (United States)

^d Cardiology Med Klinik I   (Germany)

^e Heart Center Siegburg   (Germany)

^f HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Cardiac catheterization; Femoral artery; Hemostasis; Polyethylene glycol; Vascular access

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CLOPIDOGREL; HEPARIN; HIRULOG; MACROGOL; PROTAMINE; SEALANT; THROMBIN; WARFARIN;

ADULT; AGED; ARTERIOTOMY; ARTERIOVENOUS FISTULA; ARTERY DISEASE; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEVICE; DIABETES MELLITUS; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; HEMATOMA; HEMOSTASIS; HUMAN; HYPERTENSION; INFECTION; INFLAMMATION; ISCHEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MULTICENTER STUDY; NERVE INJURY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SEPTICEMIA; TREATMENT OUTCOME; VASCULAR SURGERY; WOUND DEHISCENCE;

EID: 36348979848     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21466     Document Type: Erratum

References (12)

1. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis. J Am Coll Cardiol 2004;44:1200-1209.
2. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Catheter Cardiovasc Interv 2001;52:3-7; Discussion 8.
3. Goyen M, Manz S, Kroger K, Massalha K, Haude M, Rudofsky G. Interventional therapy of vascular complications caused by the hemostatic puncture closure device angio-seal. Catheter Cardiovasc Interv 2000;49:142-147.
4. Nehler MR, Lawrence WA, Whitehill TA, Charette SD, Jones DN, Krupski WC. Iatrogenic vascular injuries from percutaneous vascular suturing devices. J Vasc Surg 2001;33:943-947.
5. Steinkamp HJ, Werk M, Beck A, Teichgraber U, Haufe M, Felix R. Excimer laser-assisted recanalisation of femoral arterial stenosis or occlusion caused by the use of Angio-Seal. Eur Radiol 2001;11:1364-1370.
6. Wille J, Vos JA, Overtoom TT, Suttorp MJ, van de Pavoordt ED, de Vries JP. Acute leg ischemia: The dark side of a percutaneous femoral artery closure device. Ann Vasc Surg 2006;20:278-281.
7. Working PK, Newman MS, Johnson J, Cornacoff JB. Safety of Polyethylene glycol) and poly(ethylene glycol) derivatives. In: Harris JM, Zalipsky S, editors. ACS Symposium Series no. 680: Poly(ethylene) Glycol Chemistry and Biologic Applications. Washington, DC: American Chemical Society; 1997. p 45.
8. Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, et al. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 2005;17:504-510.
9. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: Systematic review and meta-analysis. JAMA 2004;291:350-357.
10. Krause PB, Klein LW. Utility of a percutaneous collagen hemostasis device: To plug or not to plug? J Am Coll Cardiol 1993;22:1280-1282.
11. Pearson ML. Guideline for prevention of intravascular device-related infections. I. Intravascular device-related infections: An overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996;24:262-277.
12. Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 2005;80:1011-1015.